These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 29902370)
1. [The Instituto Mexicano del Seguro Social gives dialysis therapies to 426 students without cost]. Méndez-Durán A; Ignorosa-Luna MH; Pérez-Aguilar G; Rivera-Rodríguez FJ; López-Ocaña LR Rev Med Inst Mex Seguro Soc; 2018; 56(2):163-166. PubMed ID: 29902370 [TBL] [Abstract][Full Text] [Related]
2. [Current status of alternative therapies renal function at the Instituto Mexicano del Seguro Social]. Méndez-Durán A; Ignorosa-Luna MH; Pérez-Aguilar G; Rivera-Rodríguez FJ; González-Izquierdo JJ; Dávila-Torres J Rev Med Inst Mex Seguro Soc; 2016; 54(5):588-93. PubMed ID: 27428340 [TBL] [Abstract][Full Text] [Related]
3. Epidemiologic and demographic aspects of peritoneal dialysis in Mexico. Su-Hernández L; Abascal-Macías A; Méndez-Bueno FJ; Paniagua R; Amato D Perit Dial Int; 1996; 16(4):362-5. PubMed ID: 8863327 [TBL] [Abstract][Full Text] [Related]
4. [Economic impact of the chronic kidney disease: Perspective of the Instituto Mexicano del Seguro Social]. Cortés-Sanabria L; Álvarez-Santana G; Orozco-González CN; Soto-Molina H; Martínez-Ramírez HR; Cueto-Manzano AM Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S124-32. PubMed ID: 29697222 [TBL] [Abstract][Full Text] [Related]
5. [Costs and sick leave due to chikungunya in the Instituto Mexicano del Seguro Social in Guerrero, Mexico]. Vázquez-Cruz I; Juanico-Morales G; Sánchez-Ramos A; Morales-Sánchez OJ Rev Med Inst Mex Seguro Soc; 2018; 56(1):54-63. PubMed ID: 29368896 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Yang F; Lau T; Luo N Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750 [TBL] [Abstract][Full Text] [Related]
7. [Seventy years of medicine in the Instituto Mexicano del Seguro Social]. Fajardo-Ortiz G Rev Med Inst Mex Seguro Soc; 2014; 52(2):228-31. PubMed ID: 24758865 [TBL] [Abstract][Full Text] [Related]
8. [Diabetes mortality in the Instituto Mexicano del Seguro Social, 1990-2005]. Fernández-Cantón S Rev Med Inst Mex Seguro Soc; 2010; 48(5):571-9. PubMed ID: 21205511 [TBL] [Abstract][Full Text] [Related]
9. [Malignant tumors as cause of disability at the Instituto Mexicano del Seguro Social]. Zitle-García EJ; Sauceda-Valenzuela AL; Ascencio-Montiel IJ; García-Paredes J Rev Med Inst Mex Seguro Soc; 2018; 56(2):173-179. PubMed ID: 29906025 [TBL] [Abstract][Full Text] [Related]
10. [Influence of Instituto Mexicano de Seguro Social in the general mortality (1990-2005)]. Fernández-Cantón S Rev Med Inst Mex Seguro Soc; 2010; 48(3):339-47. PubMed ID: 21192912 [TBL] [Abstract][Full Text] [Related]
11. Meeting Treatment Goals in Patients on Extramural Dialysis in Health Social Security in Mexico. Muñoz-Menjivar C; Reyes-Sánchez I; Aguilar-Martínez C; Rodríguez-Rodríguez A; Mendoza-Gómez JL; Guerrero-Soto J; Lizardi-Gómez LF; Venegas-Vera AV; Hernández-Rivera JCH; Ramos-Sánchez A; Paniagua R Blood Purif; 2021; 50(1):93-101. PubMed ID: 32604095 [TBL] [Abstract][Full Text] [Related]
12. The cost of renal dialysis in a UK setting--a multicentre study. Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268 [TBL] [Abstract][Full Text] [Related]
13. [Experience in training in emergencies, Division of Special Projects in Health, Instituto Mexicano del Seguro Social]. Cruz-Vega F; Loría-Castellanos J; Hernández-Olivas IP; Franco-Bey R; Ochoa-Avila C; Sánchez-Badillo V Cir Cir; 2016; 84(2):127-34. PubMed ID: 26769531 [TBL] [Abstract][Full Text] [Related]
14. [Cost of hospitalizations for older adults at one IMSS regional general hospital]. Granados-García V; Sánchez-García S; Ramírez-Aldana R; Zúñiga-Trejo C; Espinel-Bermúdez MC Rev Med Inst Mex Seguro Soc; 2018; 56(Suppl 1):S65-S70. PubMed ID: 29624974 [TBL] [Abstract][Full Text] [Related]
15. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics. Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561 [TBL] [Abstract][Full Text] [Related]
17. [The system of evaluating the specialty of pediatrics in the Instituto Mexicano del Seguro Social]. Jasso-Gutiérrez L; Serafín-Anaya F; López-Fuentes G; Arnaíz-Toledo C Bol Med Hosp Infant Mex; 1993 Nov; 50(11):837-41. PubMed ID: 8274239 [TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness of interventions for end-stage renal disease]. Arredondo A; Rangel R; de Icaza E Rev Saude Publica; 1998 Dec; 32(6):556-65. PubMed ID: 10349148 [TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia. Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178 [TBL] [Abstract][Full Text] [Related]
20. [Perception of undergraduate medical students of the educational environment at Instituto Mexicano del Seguro Social]. Morales-Gómez A; Medina-Figueroa AM Rev Med Inst Mex Seguro Soc; 2007; 45(2):123-31. PubMed ID: 17550697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]